M. Pinkevych

发表

Innate Immunity Induced by Plasmodium Liver Infection Inhibits Malaria Reinfections

M. Mota, M. Davenport, P. Liehl, 2015, Infection and Immunity.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission

Andrew J. Grimm, S. Lewin, D. Cooper, 2016, PLoS pathogens.

Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

O. McCarty, M. Davenport, Alan D. Roberts, 2013, Journal of autoimmunity.

Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population.

J. Vulule, J. Petravic, M. Davenport, 2014, The Journal of infectious diseases.

Time-to-infection by Plasmodium falciparum is largely determined by random factors

J. Vulule, M. Davenport, J. Kazura, 2015, BMC Medicine.

The Dynamics of Naturally Acquired Immunity to Plasmodium falciparum Infection

Miles P. Davenport, Mykola Pinkevych, Janka Petravic, 2012, PLoS Comput. Biol..

Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG.

M. Davenport, L. Khachigian, S. Liang, 2010, Blood.

Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo

M. Davenport, L. White, D. Cromer, 2015, PLoS neglected tropical diseases.

CD8+ lymphocytes do not impact SIV reservoir establishment under ART

Hong Wang, J. Siliciano, C. Fennessey, 2023, Nature Microbiology.

Predictors of SIV recrudescence following antiretroviral treatment interruption

J. Lifson, C. Fennessey, M. Davenport, 2019, eLife.

Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?

S. Lewin, M. Davenport, S. Kent, 2017, Journal of Virology.

Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days

S. Lewin, D. Cooper, M. Davenport, 2016, PLoS pathogens.

HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission

Anthony D. Kelleher, David A. Cooper, Miles P. Davenport, 2015, PLoS pathogens.

CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.

L. Picker, M. Davenport, B. Keele, 2021, The Journal of clinical investigation.

Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design

S. Lewin, M. Davenport, D. Cromer, 2022, The Journal of infectious diseases.

Understanding the relationship between Plasmodium falciparum growth rate and multiplicity of infection.

J. Petravic, M. Davenport, S. Bereczky, 2015, The Journal of infectious diseases.

Estimating Initial Viral Levels during Simian Immunodeficiency Virus/Human Immunodeficiency Virus Reactivation from Latency

C. Fennessey, M. Davenport, B. Keele, 2017, Journal of Virology.

Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy

J. Lifson, C. Fennessey, M. Davenport, 2017, PLoS pathogens.

Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population.

J. Vulule, J. Petravic, M. Davenport, 2013, The American journal of tropical medicine and hygiene.

Preferential selection of viral escape mutants by CD8+ T cell ‘sieving’ of SIV reactivation from latency

K. Bar, M. Paiardini, T. Schlub, 2023, PLoS pathogens.

Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication

C. Fennessey, B. Keele, M. Paiardini, 2023, PLoS pathogens.